Company Filing History:
Years Active: 2017
Title: The Innovative Mind of Hideru Obinata
Introduction
Hideru Obinata is a prominent inventor based in New York, NY, whose work has significantly contributed to the fields of biomedical engineering and vascular health. With a focus on developing novel therapeutic approaches, he has successfully secured a patent that addresses critical health issues related to endothelial cell injury.
Latest Patents
Obinata holds a notable patent for "Endothelium protective materials and methods of use," which highlights the role of Apolipoprotein M (apoM) in forming a complex with sphingosine-1-phosphate (S1P). This complex is essential for mediating endothelial protective effects and can potentially prevent and treat several diseases, such as inflammatory conditions, sepsis, atherosclerosis, and ischemic heart disease. The patent demonstrates innovative methods of administering the apoM/S1P complex, either in isolation or combined with high-density lipoprotein (HDL) particles.
Career Highlights
He is affiliated with Cornell University, where his research focuses on vascular biology and bioscience innovations. His work has not only advanced scientific understanding but also paved the way for potential clinical applications in treating serious health disorders caused by endothelial damage.
Collaborations
Throughout his career, Obinata has collaborated with esteemed colleagues, including Timothy Hla and Sylvain Galvani. Together, they have worked on various projects aimed at exploring the implications of endothelial cell function and the therapeutic potentials of their discoveries.
Conclusion
Hideru Obinata's contributions to the field of medical science through his patented innovations underscore the importance of research and collaboration in developing effective treatments for diseases related to endothelial injury. His work promises to have a lasting impact on biomedical research and therapeutic strategies.